September 2018

Letter from the Editor

September 1, 2018

In the People Business According to PhRMA, 74% of the medicines in clinical development are potentially first-in-class medicines, meaning they represent a possible new pharmacological class for treating a medical condition. Furthermore, PhRMA reports that there are 822 projects, defined as unique molecule-indication combinations, that are designated as orphan drugs, and a multitude of novel […]

Upfront

September 1, 2018

BioMarin Supports the Hemophilia Community with Theater Program BioMarin Pharmaceutical has entered into a partnership with Believe Limited to produce the Breaking Through! musical theater intensive. The first-of-its-kind program is a three-day music workshop for members of the bleeding disorders community and is designed to provide young adults with powerful educational messages on the healing […]

Innovator’s Corner

September 1, 2018

A Potential Treatment for Autism Kevin Sanders, M.D., Principal Medical Director of the Autism Program at Roche, talks about the company’s research program for balovaptan, which is being investigated to help improve social interaction and communication in people with autism. Autism, a lifelong developmental condition, affects how an individual behaves, communicates, and interacts with others. […]

Last Word

September 1, 2018

Innovation: As Many Questions As Answers John Nosta, President and Founder of Nosta Labs, challenges the status quo in discussing the state of innovation in the industry. PV: Can the pharmaceutical industry evolve based on its current organizational structure and incentives? Nosta: No, I don’t think the pharma culture wants to change. There is an […]

Agency Executive Roundtable

September 1, 2018

Heavy is the Crown Without a doubt talent — recruitment, retention, and engagement — is the biggest challenge our agency executives face today. At the same time, technology, ideation, shared value, and time are also top of mind. Sharon Callahan. TBWA\WorldHealth. The first challenge that comes to mind is keeping the best talent. As the […]

Women & Health: Addressing the Gender Gap

September 1, 2018

With 90% of CEOs in S&P 500 companies still being promoted or hired from line roles — only 20% of women in senior VP positions hold line roles — narrowing the gender gap in the C-suite will take upward of 100 years based on current trends, per research by McKinsey Global Institute. Unfortunately, study after […]

SHOWCASE: Big Data: Tapping into Big Data for Optimal Outcomes

September 1, 2018

As the industry’s reach expands to include access to anonymized electronic health record (EHR) data and genomic data, the opportunity to gather learnings on disease and treatment patterns continues to grow. The question companies face is how can they best manage big data to gain insights that will benefit the business and the patients they […]

Analytics — The Secret Sauce that Makes Data Big

September 1, 2018

“If we build it, they will come.” Most biopharmaceutical companies have spent the last few years focused on a Big Data strategy targeted at reducing costs and increasing effectiveness. Big Data platforms have been built — but did they, “they” being the patients and physicians with whom we need to engage, come? The impact has […]

Not Your Grandfather’s Graphs

September 1, 2018

Bar chart, pie chart, line graph, Kaplan-Meier… we’ve all been there and done that. In today’s information-saturated, time-challenged environment, while the tried and tested ways still have their place, it’s time for our data presentations to catch up to the needs of those who we hope will consume them. In a fast-paced data drive-by, comprehension […]

A “People First” Approach to Data Visualization

September 1, 2018

We live in an age of “data abundance” — although some might say “overload,” especially if you’ve just been confronted with a mass of information you know you need (probably even asked for), but now don’t know what to do with. You may have said you wanted information, but what you really needed was insight. […]

Changing the Channel: A Data-First Approach To Marketing

September 1, 2018

Amazon does it. Zappos does it. Even your local grocery store does it. Yes, stores are using apps to personalize your shopping experience by directing coupons to you that are the most relevant to you and your shopping habits. All of this isn’t new, but what is new is that life-sciences companies are jumping on […]

SHOWCASE: Marketing: Meeting Customers Where They Are: Marketing 3.0

September 1, 2018

Today, pharmaceutical marketers are under pressure to assess the channels and methods they have traditionally used to engage with customers in response to the changing behaviors and expectations of physicians, payers, and consumers. That could take a shift in thinking for the industry, since despite a willingness to adopt new technologies for R&D purposes, pharma […]

Is There Room for the Greater Good in Healthcare Marketing?

September 1, 2018

There was a time when the job of PR departments was either pushing out positive news of a company’s good deeds or reacting to bad news. Over the last two decades, with ever-increasing levels of digitally enabled transparency, this dynamic has shifted. Organizations need to practice what they preach daily, even hourly. And marketers know […]

Trying to Reach Healthcare Professionals and Consumers? Social Media Is the Answer.

September 1, 2018

Social media is a powerful platform for reaching HCPs and consumers alike. There are nearly 200 million active social media users in the United States alone, so it’s almost guaranteed that your target audience is using social channels, consuming content about anything and everything. So why not target them on social for your brand? Targeting […]

No Brakes: Picking the Partner to Speed Oncology and Rare Disease Candidates to Market

September 1, 2018

Imagine a company created with an end goal of delivering lifesaving therapies to patients faster while mitigating risks, minimizing obstacles, and maximizing time on market. Sounds like a turbocharged unicorn, right? Enter Precision Medicine Group (PMG)—built with a laser focus on quality and expertise. From the outset, PMG focused on overcoming the obvious perceptual barrier: […]

Creating a New Legacy: The Next Chapter

September 1, 2018

So you want to serve on a board. For many, serving on a board is a next step up the career ladder once they have reached senior leadership status. For others, serving on a board is the next chapter after their professional career has come to a successful conclusion. Serving on a board can be […]

The Business of Biologics

September 1, 2018

Since the first recombinant DNA product was approved in 1982 — Humulin developed by Genentech and marketed by Lilly — biologics have brought tremendous innovation and medical benefits to patients. More than 35 years later, the biopharma industry continues to innovate as scientific and medical knowledge advances. Biologics — large molecule drugs typically derived from […]

Brain Wave: Breakthroughs Bring New Hope to CNS

September 1, 2018

In February 2018, FDA Commissioner Scott Gottlieb, M.D., emphasized the agency’s commitment to advancing the development of novel treatments for neurological conditions. His statement recognized the uneven progress made in certain diseases and pinpointed the complex nature of neurological conditions. “The brain, in many respects, is the last organ system where many aspects of our […]

Red Zone: Avoid Enrollment Pitfalls by Engaging with Best-Fit Sites

September 1, 2018

Perhaps the single most important consideration in selecting a site is whether it can make its enrollment. Many don’t; in fact, 20-25 percent of all clinical studies close because they fail to meet enrollment targets.1 For decades, sponsors have found their “best fit” sites and returned to them for future studies. But in the era […]

Speak Out

September 1, 2018

Medical affairs is in the midst of a transformation. The dynamics of the healthcare industry, the complexity of new science, and the breadth and sophistication of communication channels that physicians have available for accessing information, are expanding the role of medical affairs and reshaping the function. In pharmaceutical companies, where departments frequently operate in silos, […]

FEEDBACK